Symbols

EVH

Evolent Health·NYSE

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 1

Consensus Rating "Strong Buy"

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About EVH

Evolent Health, Inc.

A health care company that delivers proven clinical and administrative solutions to payers and providers

Industry

Healthcare Technology

Established Date

12/12/2014

Listing Date

06/05/2015

Exchange

New York Stock Exchange

Full-time Employees

4,200

Fiscal Year Ends

12-31

Website

www.evolent.com

Security Type

Common stock

Office address

1812 N. Moore Street, Suite 1705, Arlington, Virginia 22209

Business

Introduction

Evolent Health, Inc., was incorporated in Delaware on December 12, 2014. The company is committed to providing integrated medical services to patients with complex conditions such as cancer, cardiovascular disease and musculoskeletal disease. The Company works with health insurance plans and other risk-taking entities to support healthcare providers in providing high-quality evidence-based healthcare services to patients. Evolent emphasizes the importance of following clinical pathways to improve patient outcomes, enhance physician experience, and reduce overall healthcare costs.

Company Financials

EPS

EVH has released its 2025 Q4 earnings. EPS was reported at 0.08, versus the expected 0.05, beating expectations. The chart below visualizes how EVH has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

EVH has released its 2025 Q4 earnings report, with revenue of 468.72M, reflecting a YoY change of -27.50%, and net profit of -429.13M, showing a YoY change of -1781.99%. The Sankey diagram below clearly presents EVH's revenue sources and cost distribution.